Dexamethasone (DHAP) |
| カタログ番号GC14667 |
グルココルチコイド;抗炎症作用
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1950/2/2
Sample solution is provided at 25 µL, 10mM.
評判の良い論文で引用されたGlpBio製品
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Protocol
| Cell experiment [1]: | |
|
Cell lines |
Human osteosarcoma cell lineMG-63 |
|
Preparation method |
The solubility of this compound in DMSO is >19.6mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months. |
|
Reacting condition |
100 nM; 0-36 h |
|
Applications |
In human osteoblast-like cell lineMG-63, Dexamethasone (Dex) exhibited dose-dependently upregulating RhoB protein expression. Dex treatment for above 2 days could significantly inhibit the growth of MG-63 cells in a dose dependent way. |
| Animal experiment [2]: | |
|
Animal models |
LPS-induced neuroinflammation mice |
|
Dosage form |
0.25 mg/kg; intravenous (IV) or intranasal (IN). |
|
Application |
In LPS-induced neuroinflammation mice, IN administration of DX significantly reduced the level of IL-6 in the brain extracts and reduced the percentage of GFAP+ brain cells one day after treatment. Compared with IV route, higher levels of DX are observed in the cerebrovasculature of mice after IN administration. |
|
Other notes |
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
|
References: [1]. Diao F1, Chen K2,3, Wang Y1, et al. Involvement of small G protein RhoB in the regulation of proliferation, adhesion and migration by dexamethasone in osteoblastic cells. PLoS One. 2017 Mar 21;12(3):e0174273. [2]. Meneses G1, Gevorkian G1, Florentino A1, et al. INTRANASAL DELIVERY OF DEXAMETHASONE EFFICIENTLY CONTROLS LPS-INDUCED MURINE NEUROINFLAMMATION. Clin Exp Immunol. 2017 Jul 28. | |
| Cas No. | 1950/2/2 | SDF | |
| Chemical Name | (8R,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one | ||
| Canonical SMILES | O=C1C=C[C@@]2(C)C(CC[C@@]3([H])[C@]2(F)[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(CO)=O)O)=C1 | ||
| Formula | C22H29FO5 | M.Wt | 392.46 |
| 溶解度 | ≥ 19.623mg/mL in DMSO | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.548 mL | 12.7402 mL | 25.4803 mL |
| 5 mM | 0.5096 mL | 2.548 mL | 5.0961 mL |
| 10 mM | 0.2548 mL | 1.274 mL | 2.548 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC18802 trans-Petroselinic Acid
- GC32875 AZM475271 (M475271)
- GC17509 Closantel Sodium
- GC15257 Perhexiline (maleate)
- GC17954 Tolterodine tartrate
- GC12528 NS309
- GC34568 EHMT2-IN-2
- GC17781 RK-33
- GC12932 EPZ5676
- GC16192 Diminazene Aceturate
- GC33012 IDO-IN-2
- GC30767 Heparan Sulfate
- GC19383 WNK463
- GC32114 YHO-13351
- GC32919 Kevetrin hydrochloride (4-Isothioureidobutyronitrile hydrochloride)
- GC13366 MG 624
- GC12766 G-1
レビュー
Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *